Document is current
Any future updates will be listed below
-
Authors
Moezzi, Atefeh
Ushenkina, Anastasiya
Widgren, Anna
Bergquist, Jonas
Li, Peng
Xiao, Wenzhong
Rostami-Afshari, Bita
Leveau, Corinne
Elremaly, Wesam
Caraus, Iurie
Franco, Anita
Godbout, Christian
Nepotchatykh, Oleg
Moreau, Alain
-
Funding
Funding for this research was provided by:
Institute of Musculoskeletal Health and Arthritis (MNC-166242)
Institute of Musculoskeletal Health and Arthritis (MNC-19605)
Open Medicien Foundation
Open Medicine Foundation
Estonian Research Competency Council (PRG690I)
- License Information
-
More Information
Article History
Received: 31 May 2025
Accepted: 12 August 2025
First Online: 28 August 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of CHU Sainte-Justine (protocol #4047). Informed consent was obtained from all participants involved in the study.
: Not applicable.
: Pr. Alain Moreau is the Director of the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis (ICanCME) Research Network, a national research network funded by The Canadian Institutes of Health Research (grants MNC- 166242 and MNC – 196095). Pr. Jonas Bergquist in Chief Medical Officer of Open Medicine Foundation (USA). Pr. Alain Moreau, Pr. Jonas Bergquist and Dr. Wenzhong Xiao are Members of the Scientific Advisory Board of the Open Medicine Foundation (USA).
